Paper · 35600577
Latest Advancements on Combating Obesity by Targeting Human Brown/Beige Adipose Tissues.
Pan R and 1 other. Front Endocrinol (Lausanne), 2022. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Latest Advancements on Combating Obesity by Targeting Human Brown/Beige Adipose Tissues. Papers, record 35600577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35600577
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Metabolic Diseases | Major topic |
| Adipose Tissue, Beige | |
| Adipose Tissue, Brown | |
| Humans | |
| Obesity | |
| Positron Emission Tomography Computed Tomography |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33,013,706 | Metabolic Improvement via Enhancing Thermogenic Fat-Mediated Non-shivering Thermogenesis: From Rodents to Humans. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33013706 | PubMed |
| 2 | 30,325,968 | Cardiovascular risk profile in individuals initiating treatment for overactive bladder - Challenges and learnings for comparative analysis using linked claims and electronic medical record databases. | PLoS One | 2018 | https://conductscience.org/library/papers/30325968 | PubMed |
| 3 | 30,661,513 | Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial. | Eur Urol | 2019 | https://conductscience.org/library/papers/30661513 | PubMed |
| 4 | 34,100,382 | β3-Adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis. | JCI Insight | 2021 | https://conductscience.org/library/papers/34100382 | PubMed |
| 5 | 32,435,180 | Involvement of Secretin in the Control of Cell Survival and Synaptic Plasticity in the Central Nervous System. | Front Neurosci | 2020 | https://conductscience.org/library/papers/32435180 | PubMed |
| 6 | 33,398,160 | Brown adipose tissue is associated with cardiometabolic health. | Nat Med | 2021 | https://conductscience.org/library/papers/33398160 | PubMed |
| 7 | 34,048,700 | Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis. | Cell | 2021 | https://conductscience.org/library/papers/34048700 | PubMed |
| 8 | 30,411,311 | Vibegron: First Global Approval. | Drugs | 2018 | https://conductscience.org/library/papers/30411311 | PubMed |
| 9 | 408,145 | Plasma secretin concentration in man: effect of intraduodenal glucose, fat, amino acids, ethanol, HCl, or ingestion of a meal. | Eur J Clin Invest | 1977 | https://conductscience.org/library/papers/408145 | PubMed |
| 10 | 30,496,126 | FGF9 inhibits browning program of white adipocytes and associates with human obesity. | J Mol Endocrinol | 2019 | https://conductscience.org/library/papers/30496126 | PubMed |
1 to 10 of 55
See all 55 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,497,271 | Significance of neuroendocrine systems and the gut-brain axis (GBA) in the regulation of obesity. | PeerJ | 2026 | https://conductscience.org/library/papers/41497271 | PubMed |
| 38,577,419 | Dietary kaempferol exerts anti-obesity effects by inducing the browing of white adipocytes via the AMPK/SIRT1/PGC-1α signaling pathway. | Curr Res Food Sci | 2024 | https://conductscience.org/library/papers/38577419 | PubMed |
| 37,948,566 | Use of FGF21 analogs for the treatment of metabolic disorders: a systematic review and meta-analysis. | Arch Endocrinol Metab | 2023 | https://conductscience.org/library/papers/37948566 | PubMed |
| 37,680,891 | Latest advances in the regulatory genes of adipocyte thermogenesis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37680891 | PubMed |
| 37,435,495 | Treatment of obesity-related diabetes: significance of thermogenic adipose tissue and targetable receptors. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37435495 | PubMed |
| 37,110,178 | High-Fat-Diet Suppressed Ketone Body Utilization for Lipogenic Pathway in Brown Adipose Tissues. | Metabolites | 2023 | https://conductscience.org/library/papers/37110178 | PubMed |
| 35,806,493 | LncRNA-Mediated Adipogenesis in Different Adipocytes. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806493 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADORA2A | 135 | PubTator's text mining | https://conductscience.org/library/genes/135 | NCBI Gene |
| ADORA2B | 136 | PubTator's text mining | https://conductscience.org/library/genes/136 | NCBI Gene |
| ADRB1 | 153 | PubTator's text mining | https://conductscience.org/library/genes/153 | NCBI Gene |
| ADRB2 | 154 | PubTator's text mining | https://conductscience.org/library/genes/154 | NCBI Gene |
| ADRB3 | 155 | PubTator's text mining | https://conductscience.org/library/genes/155 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| APOA1 | 335 | PubTator's text mining | https://conductscience.org/library/genes/335 | NCBI Gene |
| CAMP | 820 | PubTator's text mining | https://conductscience.org/library/genes/820 | NCBI Gene |
| DLAT | 1,737 | PubTator's text mining | https://conductscience.org/library/genes/1737 | NCBI Gene |
| ESRRA | 2,101 | PubTator's text mining | https://conductscience.org/library/genes/2101 | NCBI Gene |
1 to 10 of 38
See all 38 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35600577
GET https://conductscience.org/api/papers/v1/35600577/references?page=2